Patient reported outcome measures (PROMs): examination of the psychometric properties of two measures for burden of symptoms and quality of life in patients with depression or anxiety

被引:27
作者
Bech, Per [1 ]
Austin, Stephen Fitzgerald [1 ,2 ]
Lau, Marianne Engelbrecht [3 ]
机构
[1] Copenhagen Univ Hosp, Psychiat Res Unit, Psychiat Ctr North Zealand, Hillerod, Denmark
[2] Reg Zealand Psychiat, Psychiat Res Unit, Roskilde, Denmark
[3] Stolpegaard Psychotherapy Ctr, Mental Hlth Serv, Gentofte, Denmark
关键词
Patient-reported outcomes; measurement-based care; psychometrics; anxiety and depressive disorders; treatment evaluation; MEASUREMENT-BASED CARE; STANDARDIZATION; VALIDATION; VERSION; HEALTH; SCL-90;
D O I
10.1080/08039488.2018.1451918
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Patient-reported outcome measures (PROMs) for anxiety and depressive disorders are an important aspect of measurement-based care.Aim: The aim of the study was to perform a clinimetric analysis of two PROMs scales in patents with depression and anxiety.Methods: Patients completed a 10-item version (SCL-10) of the Symptom Checklist to measure burden of symptoms and a brief 5-item version of World Health Organization Well-being scale (WHO-5) to measure quality of life. T-scores were used to standardize the SCL-10 and WHO-5 in terms of being in need of treatment. The coefficient of alpha and the coefficient of homogeneity were used to evaluate the internal consistency or scalability respectively of SCL-10 and WHO-5. Effect size statistics and Spearman correlation coefficients were used to measure the effect of gender and age, respectively.Results: A total of 801 patients were recruited from two Danish mental health centers with anxiety or depression. The standardization of the SCL-10 and WHO-5 by T-scores indicated that a T-score of 65 corresponding to being moderately in need of treatment and a T-score of 75 to be severely in need of treatment. The coefficient of alpha and the coefficient of homogeneity were both found acceptable for SCL-10 and WHO-5. No gender or age factors were found being in operation.Conclusion: The results from the current study supported the use of the SCL-10 and WHO-5 as potential PROMs to capture symptom burden and quality of life within groups of people with anxiety or depression undergoing psychotherapy treatment.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 29 条
[1]  
[Anonymous], 2012, CLIN PSYCHOMETRICS, DOI DOI 10.1002/9781118511800.APP15
[2]  
[Anonymous], USERS MANUAL MSP PRO
[3]  
[Anonymous], 2016, MEASUREMENT BASED CA, DOI DOI 10.1007/978-3-319-46651-4
[4]   A pharmacopsychometric overview of major depressive episodes in positive psychiatry [J].
Bech, P. .
INTERNATIONAL PSYCHOGERIATRICS, 2018, 30 (06) :833-841
[5]   Psychometric validation of the Hopkins Symptom Checklist (SCL-90) subscales for depression, anxiety, and interpersonal sensitivity [J].
Bech, P. ;
Bille, J. ;
Moller, S. B. ;
Hellstrom, L. C. ;
Ostergaard, S. D. .
JOURNAL OF AFFECTIVE DISORDERS, 2014, 160 :98-103
[6]   Clinimetric Dilemmas in Outcome Scales for Mental Disorders [J].
Bech, Per .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2016, 85 (06) :323-326
[7]  
Bech P, 2015, POSITIVE PSYCHIATRY: A CLINICAL HANDBOOK, P127
[8]   Testing and standardization of the German version of the EUROHIS-QOL and WHO-5 quality-of life-indices [J].
Braeher, Elmar ;
Muehlan, Holger ;
Albani, Cornelia ;
Schmidt, Silke .
DIAGNOSTICA, 2007, 53 (02) :83-96
[9]   Measuring depression severity in general practice: discriminatory performance of the PHQ-9, HADS-D, and BDI-II [J].
Cameron, Isobel M. ;
Cardy, Amanda ;
Crawford, John R. ;
du Toit, Schalk W. ;
Hay, Steven ;
Lawton, Kenneth ;
Mitchell, Kenneth ;
Sharma, Sumit ;
Shivaprasad, Shilpa ;
Winning, Sally ;
Reid, Ian C. .
BRITISH JOURNAL OF GENERAL PRACTICE, 2011, 61 (588) :e419-e426
[10]   Evaluating psychiatric symptoms in Parkinson's Disease by a clinimetric analysis of the Hopkins Symptom Checklist (SCL-90-R) [J].
Carrozzino, Danilo ;
Morberg, Bo Mohr ;
Siri, Chiara ;
Pezzoli, Gianni ;
Bech, Per .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2018, 81 :131-137